1 citations
,
April 2023 in “Preprints.org” SEFFI is a safe and effective anti-aging treatment with few complications.
1 citations
,
March 2022 in “Journal of The American Academy of Dermatology” Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.
1 citations
,
November 2014 in “Thérapie” Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.
1 citations
,
May 2011 in “Hair transplant forum international” Injectable ACell with blood serum/PRP may slow hair loss and regrow thinning hair.
April 2026 in “Clinical Cosmetic and Investigational Dermatology” Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.
TSH levels are similar across nonscarring alopecia types, with unclear racial differences.
March 2026 in “The Journal of Sexual Medicine” Hormone therapy can improve sexual health and quality of life for women 70 and older.
February 2026 in “Clinical Drug Investigation” Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.
The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.
February 2026 in “Indian Journal of Dermatology” Adults are more reactive to allergens than older adults, who are more sensitive to medication-related allergens.
February 2026 in “JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH” Trichoscopy effectively detects early hair follicle changes before visible baldness in men under 40.
January 2026 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Deep-learning models can effectively diagnose and assess Alopecia areata using scalp images.
Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.
December 2025 in “Actas Dermo-Sifiliográficas”
November 2025 in “American Journal of Tropical Medicine and Hygiene” Low platelet count and hematocrit may increase the risk of hair loss in dengue fever patients.
July 2025 in “Actas Dermo-Sifiliográficas” Trichodynia is a challenging scalp condition to treat, needing gentle care and more research for better solutions.
July 2025 in “Lasers in Surgery and Medicine” Non-ablative fractional laser treatment safely improves hair growth and scalp appearance.
July 2025 in “Plastic & Reconstructive Surgery” Managing expectations and using skilled techniques are key for patient satisfaction in hairline transplants.
June 2025 in “The Journal of Dermatology” Baricitinib is effective and safe for long-term treatment of severe alopecia areata.
May 2025 in “Journal of Cosmetic Dermatology” Post-finasteride syndrome may be linked to pre-existing psychological issues, not just the drug.
April 2025 in “Journal of the American Academy of Dermatology” The study has limitations, and future research should use better methods to improve treatment for children with hair loss.
February 2025 in “Journal of the American Academy of Dermatology” People with androgenetic alopecia may have a higher risk of peripheral venous disorders.
Combined oral minoxidil and finasteride significantly improve hair density in men with male pattern baldness.
September 2024 in “Actas Dermo-Sifiliográficas” Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.
February 2024 in “Acta dermato-venereologica” This type of hair loss is probably often missed and treatments reducing inflammation might work well.
December 2023 in “Journal of the American Academy of Dermatology” Refugee patients face long wait times for dermatology care, worsening health disparities.
August 2023 in “Journal of the American Academy of Dermatology” The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.
July 2023 in “Dermatology practical & conceptual” Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.
Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.
Quality of life improved after COVID-19, but ongoing health support is needed.